Global cancer medication prices in comparison to the U.S., 2018
Although there was variation in the ex-factory price between select cancer medications, in all cases the U.S. price per dose was higher than the average of the 11 other countries in this analysis. The four drugs with the highest U.S.-international price differentials were Ibrance, Afinitor, Sprycel and Zytiga. International prices from selected developed countries were compared to U.S. drug prices under Medicare Part D.